Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U2 small nuclear 5, pseudogene (RNU2-5P) is a human non-coding RNA pseudogene located in the U2 snRNA multigene family. True U2 small nuclear RNAs are essential components of the spliceosome complex, responsible for pre-mRNA splicing in eukaryotic cells, but RNU2-5P is classified as a pseudogene, meaning it resembles functional genes but contains mutations or structural changes that prevent proper function or expression of the mature snRNA[1][5]. As a non-coding and non-functional sequence, RNU2-5P has no known direct biological function, disease association, or role as a therapeutic target. Its presence reflects the repetitive and dynamic organization of snRNA gene families in the genome, with only a subset of U2 sequence copies being transcriptionally active and functionally relevant[1][4][3]. If highly structured information is needed, this molecule should be excluded from lists of therapeutic targets, as it is not a receptor, enzyme, transporter, or established drug target.
None (mechanism of action information does not apply to pseudogene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U2 small nuclear 5, pseudogene (RNU2-5P).